NCT06793865 Effect of Russian Current Stimulation for Anterior Tibial Group on Postural Stability and Risk of Falling in Patients With Stroke
| NCT ID | NCT06793865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-10 |
| Primary Completion | 2025-02-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-10-10 with a primary completion date of 2025-02-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to examine the effect of Russian current stimulation on Anterior tibial group on postural stability and risk of falling in patients with stroke.
Eligibility Criteria
Inclusion Criteria: * Forty patient with stroke manifest with weakness of anterior tibial group. * Patients with moderate spasticity, * Patient's ages ranged from 40-55 years. * Patients BMI not exceed 30 kg/m². * Medically and clinically stable patients. Exclusion Criteria: * Patients suffering from psychological, cognitive, or emotional disturbance. * Patients with severe spasticity (3 or more by the modified Ashworth scale). * Patients with atrial fibrillation. * Patients with infectious processes. * Patients with impaired pain sensitivity. * Patients with epilepsy. * Patients with lower limb joint endoprosthetics.
Contact & Investigator
Hoda Mohamed Zakaria, PhD
STUDY CHAIR
Professor, Cairo University
Frequently Asked Questions
Who can join the NCT06793865 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 55 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793865 currently recruiting?
Yes, NCT06793865 is actively recruiting participants. Contact the research team at abdelrahmanrefaat56@gmail.com for enrollment information.
Where is the NCT06793865 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT06793865 clinical trial?
NCT06793865 is sponsored by Cairo University. The principal investigator is Hoda Mohamed Zakaria, PhD at Professor, Cairo University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.